… assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild
cognitive impairment and predicting Alzheimer’s disease risk. Altoida’s Digital Neuro Signature (…

… A strong similarity with AD pathological patterns indicates the presence of an AD MRI
signature and thus reveals that the neurodegeneration process related to AD has started. This …

Alzheimer's disease (AD) is a devastating … disease's critical early stages. In a prior microarray
study we correlated gene expression in hippocampus with degree of Alzheimer's disease …

… According to this interpretation, the network signatures … : how does the single pathological
entity of AD give rise to … disease, the pathology associated with these disease variants is …

… Aβ plaque pathology only and subjects with Aβ plaque pathology together with CAA pathology.
… This information may be useful in the development of pathology-specific biomarkers. …

… Alzheimer disease (AD) is the most common form of … We present a novel miRNA-based
signature for detecting AD … Using this 12-miRNA signature, we differentiate between AD and …

… of hypotheses related to particular stages of Alzheimer's disease from Medline abstracts. …
efficient diagnosis of the disease is important not only to rule out non-AD pathology but also to …

… beta sheet structure forming pathological aggregates believed to cause … is a pathological
hallmark of Alzheimer disease (AD) and … heterogeneous neurodegenerative diseases including …

… Using antibodies to different forms of Aβ peptide and blocking protocols, we demonstrate
that most of this signature is not due to the subject's antibodies raised against Aβ. …

… signatures that may act as surrogate markers of the pathophysiological changes that occur in
the predementia stages of Alzheimer’s disease. Further… of potential MEG signatures, we first …